- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–12 of 133
Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Overview: Results for Nonstandard Interventions to Treat CDI or Reduce the Risk of Recurrence
Nonstandard Interventions for Treatment of Multiple Recurrences of CDI
Prevention Strategies for CDI Focusing on Antibiotic Prescribing Policies
Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Population and Applicability
Presentation: Assessing Applicability
Keywords: applicability | population | eligibility criteria | exclusion criteria
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Relative Hematoma Expansion Is Reduced After rFVIIa Use in Spontaneous Intracranial Hemorrhage
Background: Treatment of GERD (1 of 2)
Background: Treatment of GERD (2 of 2)
Findings of the Comparative Effectiveness Review: Medication (1 of 3)
Your slide tray is being processed.